abstract |
The invention relates to substituted pyrido[1,2-a]pyrimidine compounds corresponding to formula (I) wherein: R<SUP>1</SUP>, R<SUP>2 </SUP>and R<SUP>3 </SUP>are as defined in the specification. Related pharmaceutical formulations and methods for inhibiting nitrogen oxide synthesis (NOS) and other treatments are also provided. |